Cover Image
Market Research Report

Global Rare Disease Treatment Market Size, Status and Forecast 2019-2025

Published by QYResearch Product code 797926
Published Content info 104 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Rare Disease Treatment Market Size, Status and Forecast 2019-2025
Published: July 9, 2019 Content info: 104 Pages
Description

A rare disease is any disease that affects a small percentage of the population.

Most rare diseases are genetic and thus are present throughout the person's entire life, even if symptoms do not immediately appear.

In 2018, the global Rare Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Rare Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rare Disease Treatment development in United States, Europe and China.

The key players covered in this study

  • Novartis
  • Pfizer
  • F. Hoffmann-La Roche
  • Celgene
  • AbbVie
  • Johnson & Johnson
  • Shire
  • Alexion
  • Novo Nordisk
  • Sanofi
  • Bayer
  • Amgen
  • Allergan
  • Eisai
  • Bristol-Myers Squibb
  • Merck
  • Vertex Pharmaceuticals
  • Baxter
  • BioMarin
  • Teva Pharmaceutical Industries

Market segment by Type, the product can be split into

  • Originator Drugs
  • Generic Drugs

Market segment by Application, split into

  • Hospital Pharmacies
  • Specialty Pharmacies
  • Retail Pharmacies

Market segment by Regions/Countries, this report covers

  • United States
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America

The study objectives of this report are:

  • To analyze global Rare Disease Treatment status, future forecast, growth opportunity, key market and key players.
  • To present the Rare Disease Treatment development in United States, Europe and China.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Rare Disease Treatment are as follows:

  • History Year: 2014-2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Rare Disease Treatment Market Size Growth Rate by Type (2014-2025)
    • 1.4.2 Originator Drugs
    • 1.4.3 Generic Drugs
  • 1.5 Market by Application
    • 1.5.1 Global Rare Disease Treatment Market Share by Application (2014-2025)
    • 1.5.2 Hospital Pharmacies
    • 1.5.3 Specialty Pharmacies
    • 1.5.4 Retail Pharmacies
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Rare Disease Treatment Market Size
  • 2.2 Rare Disease Treatment Growth Trends by Regions
    • 2.2.1 Rare Disease Treatment Market Size by Regions (2014-2025)
    • 2.2.2 Rare Disease Treatment Market Share by Regions (2014-2019)
  • 2.3 Industry Trends
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Opportunities

3 Market Share by Key Players

  • 3.1 Rare Disease Treatment Market Size by Manufacturers
    • 3.1.1 Global Rare Disease Treatment Revenue by Manufacturers (2014-2019)
    • 3.1.2 Global Rare Disease Treatment Revenue Market Share by Manufacturers (2014-2019)
    • 3.1.3 Global Rare Disease Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.2 Rare Disease Treatment Key Players Head office and Area Served
  • 3.3 Key Players Rare Disease Treatment Product/Solution/Service
  • 3.4 Date of Enter into Rare Disease Treatment Market
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

  • 4.1 Global Rare Disease Treatment Market Size by Type (2014-2019)
  • 4.2 Global Rare Disease Treatment Market Size by Application (2014-2019)

5 United States

  • 5.1 United States Rare Disease Treatment Market Size (2014-2019)
  • 5.2 Rare Disease Treatment Key Players in United States
  • 5.3 United States Rare Disease Treatment Market Size by Type
  • 5.4 United States Rare Disease Treatment Market Size by Application

6 Europe

  • 6.1 Europe Rare Disease Treatment Market Size (2014-2019)
  • 6.2 Rare Disease Treatment Key Players in Europe
  • 6.3 Europe Rare Disease Treatment Market Size by Type
  • 6.4 Europe Rare Disease Treatment Market Size by Application

7 China

  • 7.1 China Rare Disease Treatment Market Size (2014-2019)
  • 7.2 Rare Disease Treatment Key Players in China
  • 7.3 China Rare Disease Treatment Market Size by Type
  • 7.4 China Rare Disease Treatment Market Size by Application

8 Japan

  • 8.1 Japan Rare Disease Treatment Market Size (2014-2019)
  • 8.2 Rare Disease Treatment Key Players in Japan
  • 8.3 Japan Rare Disease Treatment Market Size by Type
  • 8.4 Japan Rare Disease Treatment Market Size by Application

9 Southeast Asia

  • 9.1 Southeast Asia Rare Disease Treatment Market Size (2014-2019)
  • 9.2 Rare Disease Treatment Key Players in Southeast Asia
  • 9.3 Southeast Asia Rare Disease Treatment Market Size by Type
  • 9.4 Southeast Asia Rare Disease Treatment Market Size by Application

10 India

  • 10.1 India Rare Disease Treatment Market Size (2014-2019)
  • 10.2 Rare Disease Treatment Key Players in India
  • 10.3 India Rare Disease Treatment Market Size by Type
  • 10.4 India Rare Disease Treatment Market Size by Application

11 Central & South America

  • 11.1 Central & South America Rare Disease Treatment Market Size (2014-2019)
  • 11.2 Rare Disease Treatment Key Players in Central & South America
  • 11.3 Central & South America Rare Disease Treatment Market Size by Type
  • 11.4 Central & South America Rare Disease Treatment Market Size by Application

12 International Players Profiles

  • 12.1 Novartis
    • 12.1.1 Novartis Company Details
    • 12.1.2 Company Description and Business Overview
    • 12.1.3 Rare Disease Treatment Introduction
    • 12.1.4 Novartis Revenue in Rare Disease Treatment Business (2014-2019)
    • 12.1.5 Novartis Recent Development
  • 12.2 Pfizer
    • 12.2.1 Pfizer Company Details
    • 12.2.2 Company Description and Business Overview
    • 12.2.3 Rare Disease Treatment Introduction
    • 12.2.4 Pfizer Revenue in Rare Disease Treatment Business (2014-2019)
    • 12.2.5 Pfizer Recent Development
  • 12.3 F. Hoffmann-La Roche
    • 12.3.1 F. Hoffmann-La Roche Company Details
    • 12.3.2 Company Description and Business Overview
    • 12.3.3 Rare Disease Treatment Introduction
    • 12.3.4 F. Hoffmann-La Roche Revenue in Rare Disease Treatment Business (2014-2019)
    • 12.3.5 F. Hoffmann-La Roche Recent Development
  • 12.4 Celgene
    • 12.4.1 Celgene Company Details
    • 12.4.2 Company Description and Business Overview
    • 12.4.3 Rare Disease Treatment Introduction
    • 12.4.4 Celgene Revenue in Rare Disease Treatment Business (2014-2019)
    • 12.4.5 Celgene Recent Development
  • 12.5 AbbVie
    • 12.5.1 AbbVie Company Details
    • 12.5.2 Company Description and Business Overview
    • 12.5.3 Rare Disease Treatment Introduction
    • 12.5.4 AbbVie Revenue in Rare Disease Treatment Business (2014-2019)
    • 12.5.5 AbbVie Recent Development
  • 12.6 Johnson & Johnson
    • 12.6.1 Johnson & Johnson Company Details
    • 12.6.2 Company Description and Business Overview
    • 12.6.3 Rare Disease Treatment Introduction
    • 12.6.4 Johnson & Johnson Revenue in Rare Disease Treatment Business (2014-2019)
    • 12.6.5 Johnson & Johnson Recent Development
  • 12.7 Shire
    • 12.7.1 Shire Company Details
    • 12.7.2 Company Description and Business Overview
    • 12.7.3 Rare Disease Treatment Introduction
    • 12.7.4 Shire Revenue in Rare Disease Treatment Business (2014-2019)
    • 12.7.5 Shire Recent Development
  • 12.8 Alexion
    • 12.8.1 Alexion Company Details
    • 12.8.2 Company Description and Business Overview
    • 12.8.3 Rare Disease Treatment Introduction
    • 12.8.4 Alexion Revenue in Rare Disease Treatment Business (2014-2019)
    • 12.8.5 Alexion Recent Development
  • 12.9 Novo Nordisk
    • 12.9.1 Novo Nordisk Company Details
    • 12.9.2 Company Description and Business Overview
    • 12.9.3 Rare Disease Treatment Introduction
    • 12.9.4 Novo Nordisk Revenue in Rare Disease Treatment Business (2014-2019)
    • 12.9.5 Novo Nordisk Recent Development
  • 12.10 Sanofi
    • 12.10.1 Sanofi Company Details
    • 12.10.2 Company Description and Business Overview
    • 12.10.3 Rare Disease Treatment Introduction
    • 12.10.4 Sanofi Revenue in Rare Disease Treatment Business (2014-2019)
    • 12.10.5 Sanofi Recent Development
  • 12.11 Bayer
  • 12.12 Amgen
  • 12.13 Allergan
  • 12.14 Eisai
  • 12.15 Bristol-Myers Squibb
  • 12.16 Merck
  • 12.17 Vertex Pharmaceuticals
  • 12.18 Baxter
  • 12.19 BioMarin
  • 12.20 Teva Pharmaceutical Industries

13 Market Forecast 2019-2025

  • 13.1 Market Size Forecast by Regions
  • 13.2 United States
  • 13.3 Europe
  • 13.4 China
  • 13.5 Japan
  • 13.6 Southeast Asia
  • 13.7 India
  • 13.8 Central & South America
  • 13.9 Market Size Forecast by Product (2019-2025)
  • 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
      • 15.1.1.1 Research Programs/Design
      • 15.1.1.2 Market Size Estimation
      • 12.1.1.3 Market Breakdown and Data Triangulation
    • 15.1.2 Data Source
      • 15.1.2.1 Secondary Sources
      • 15.1.2.2 Primary Sources
  • 15.2 Disclaimer
  • 15.3 Author Details

List of Tables and Figures

  • Table Rare Disease Treatment Key Market Segments
  • Table Key Players Rare Disease Treatment Covered
  • Table Global Rare Disease Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
  • Figure Global Rare Disease Treatment Market Size Market Share by Type 2014-2025
  • Figure Originator Drugs Figures
  • Table Key Players of Originator Drugs
  • Figure Generic Drugs Figures
  • Table Key Players of Generic Drugs
  • Table Global Rare Disease Treatment Market Size Growth by Application 2014-2025 (Million US$)
  • Figure Hospital Pharmacies Case Studies
  • Figure Specialty Pharmacies Case Studies
  • Figure Retail Pharmacies Case Studies
  • Figure Rare Disease Treatment Report Years Considered
  • Table Global Rare Disease Treatment Market Size 2014-2025 (Million US$)
  • Figure Global Rare Disease Treatment Market Size and Growth Rate 2014-2025 (Million US$)
  • Table Global Rare Disease Treatment Market Size by Regions 2014-2025 (Million US$)
  • Table Global Rare Disease Treatment Market Size by Regions 2014-2019 (Million US$)
  • Table Global Rare Disease Treatment Market Share by Regions 2014-2019
  • Figure Global Rare Disease Treatment Market Share by Regions 2014-2019
  • Figure Global Rare Disease Treatment Market Share by Regions 2019
  • Table Market Top Trends
  • Table Global Rare Disease Treatment Revenue by Manufacturers (2014-2019) (Million US$)
  • Table Global Rare Disease Treatment Market Share by Manufacturers (2014-2019)
  • Figure Global Rare Disease Treatment Market Share by Manufacturers in 2018
  • Table Global Rare Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Players Head office and Area Served
  • Table Key Players Rare Disease Treatment Product/Solution/Service
  • Table Date of Enter into Rare Disease Treatment Market
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Rare Disease Treatment Market Size by Type (2014-2019) (Million US$)
  • Table Global Rare Disease Treatment Market Size Share by Type (2014-2019)
  • Figure Global Rare Disease Treatment Market Size Market Share by Type (2014-2019)
  • Table Global Rare Disease Treatment Market Size by Application (2014-2019) (Million US$)
  • Table Global Rare Disease Treatment Market Size Share by Application (2014-2019)
  • Figure Global Rare Disease Treatment Market Size Market Share by Application (2014-2019)
  • Figure Global Rare Disease Treatment Revenue Market Share by Application in 2018
  • Figure United States Rare Disease Treatment Market Size 2014-2019 (Million US$)
  • Table United States Key Players Rare Disease Treatment Revenue (2018-2019) (Million US$)
  • Table United States Key Players Rare Disease Treatment Market Share (2018-2019)
  • Table United States Rare Disease Treatment Market Size by Type (2014-2019) (Million US$)
  • Table United States Rare Disease Treatment Market Share by Type (2014-2019)
  • Table United States Rare Disease Treatment Market Size by Application (2014-2019) (Million US$)
  • Table United States Rare Disease Treatment Market Share by Application (2014-2019)
  • Figure Europe Rare Disease Treatment Market Size 2014-2019 (Million US$)
  • Table Europe Key Players Rare Disease Treatment Revenue (2018-2019) (Million US$)
  • Table Europe Key Players Rare Disease Treatment Market Share (2018-2019)
  • Table Europe Rare Disease Treatment Market Size by Type (2014-2019) (Million US$)
  • Table Europe Rare Disease Treatment Market Share by Type (2014-2019)
  • Table Europe Rare Disease Treatment Market Size by Application (2014-2019) (Million US$)
  • Table Europe Rare Disease Treatment Market Share by Application (2014-2019)
  • Figure China Rare Disease Treatment Market Size 2014-2019 (Million US$)
  • Table China Key Players Rare Disease Treatment Revenue (2018-2019) (Million US$)
  • Table China Key Players Rare Disease Treatment Market Share (2018-2019)
  • Table China Rare Disease Treatment Market Size by Type (2014-20189) (Million US$)
  • Table China Rare Disease Treatment Market Share by Type (2014-2019)
  • Table China Rare Disease Treatment Market Size by Application (2014-2019) (Million US$)
  • Table China Rare Disease Treatment Market Share by Application (2014-2019)
  • Figure Japan Rare Disease Treatment Market Size 2014-2019 (Million US$)
  • Table Japan Key Players Rare Disease Treatment Revenue (2018-2019) (Million US$)
  • Table Japan Key Players Rare Disease Treatment Market Share (2018-2019)
  • Table Japan Rare Disease Treatment Market Size by Type (2014-2019) (Million US$)
  • Table Japan Rare Disease Treatment Market Share by Type (2014-2019)
  • Table Japan Rare Disease Treatment Market Size by Application (2014-2019) (Million US$)
  • Table Japan Rare Disease Treatment Market Share by Application (2014-2019)
  • Figure Southeast Asia Rare Disease Treatment Market Size 2014-2019 (Million US$)
  • Table Southeast Asia Key Players Rare Disease Treatment Revenue (2018-2019) (Million US$)
  • Table Southeast Asia Key Players Rare Disease Treatment Market Share (2018-2019)
  • Table Southeast Asia Rare Disease Treatment Market Size by Type (2014-2019) (Million US$)
  • Table Southeast Asia Rare Disease Treatment Market Share by Type (2014-2019)
  • Table Southeast Asia Rare Disease Treatment Market Size by Application (2014-2019) (Million US$)
  • Table Southeast Asia Rare Disease Treatment Market Share by Application (2014-2019)
  • Figure India Rare Disease Treatment Market Size 2014-2019 (Million US$)
  • Table India Key Players Rare Disease Treatment Revenue (2018-2019) (Million US$)
  • Table India Key Players Rare Disease Treatment Market Share (2018-2019)
  • Table India Rare Disease Treatment Market Size by Type (2014-2019) (Million US$)
  • Table India Rare Disease Treatment Market Share by Type (2014-2019)
  • Table India Rare Disease Treatment Market Size by Application (2014-2019) (Million US$)
  • Table India Rare Disease Treatment Market Share by Application (2014-2019)
  • Figure Central & South America Rare Disease Treatment Market Size 2014-2019 (Million US$)
  • Table Central & South America Key Players Rare Disease Treatment Revenue (2018-2019) (Million US$)
  • Table Central & South America Key Players Rare Disease Treatment Market Share (2018-2019)
  • Table Central & South America Rare Disease Treatment Market Size by Type (2014-2019) (Million US$)
  • Table Central & South America Rare Disease Treatment Market Share by Type (2014-2019)
  • Table Central & South America Rare Disease Treatment Market Size by Application (2014-2019) (Million US$)
  • Table Central & South America Rare Disease Treatment Market Share by Application (2014-2019)
  • Table Novartis Company Details
  • Table Novartis Revenue in Rare Disease Treatment Business (2014-2019) (Million US$)
  • Figure Novartis Revenue Growth Rate in Rare Disease Treatment Business (2014-2019)
  • Table Novartis Recent Development
  • Table Pfizer Company Details
  • Table Pfizer Revenue in Rare Disease Treatment Business (2014-2019)(Million US$)
  • Figure Pfizer Revenue Growth Rate in Rare Disease Treatment Business (2014-2019)
  • Table Pfizer Recent Development
  • Table F. Hoffmann-La Roche Company Details
  • Table F. Hoffmann-La Roche Revenue in Rare Disease Treatment Business (2014-2019)(Million US$)
  • Figure F. Hoffmann-La Roche Revenue Growth Rate in Rare Disease Treatment Business (2014-2019)
  • Table F. Hoffmann-La Roche Recent Development
  • Table Celgene Company Details
  • Table Celgene Revenue in Rare Disease Treatment Business (2014-2019)(Million US$)
  • Figure Celgene Revenue Growth Rate in Rare Disease Treatment Business (2014-2019)
  • Table Celgene Recent Development
  • Table AbbVie Company Details
  • Table AbbVie Revenue in Rare Disease Treatment Business (2014-2019)(Million US$)
  • Figure AbbVie Revenue Growth Rate in Rare Disease Treatment Business (2014-2019)
  • Table AbbVie Recent Development
  • Table Johnson & Johnson Company Details
  • Table Johnson & Johnson Revenue in Rare Disease Treatment Business (2014-2019)(Million US$)
  • Figure Johnson & Johnson Revenue Growth Rate in Rare Disease Treatment Business (2014-2019)
  • Table Johnson & Johnson Recent Development
  • Table Shire Company Details
  • Table Shire Revenue in Rare Disease Treatment Business (2014-2019)(Million US$)
  • Figure Shire Revenue Growth Rate in Rare Disease Treatment Business (2014-2019)
  • Table Shire Recent Development
  • Table Alexion Company Details
  • Table Alexion Revenue in Rare Disease Treatment Business (2014-2019)(Million US$)
  • Figure Alexion Revenue Growth Rate in Rare Disease Treatment Business (2014-2019)
  • Table Alexion Recent Development
  • Table Novo Nordisk Company Details
  • Table Novo Nordisk Revenue in Rare Disease Treatment Business (2014-2019)(Million US$)
  • Figure Novo Nordisk Revenue Growth Rate in Rare Disease Treatment Business (2014-2019)
  • Table Novo Nordisk Recent Development
  • Table Sanofi Company Details
  • Table Sanofi Revenue in Rare Disease Treatment Business (2014-2019)(Million US$)
  • Figure Sanofi Revenue Growth Rate in Rare Disease Treatment Business (2014-2019)
  • Table Sanofi Recent Development
  • Table Bayer Company Details
  • Table Amgen Company Details
  • Table Allergan Company Details
  • Table Eisai Company Details
  • Table Bristol-Myers Squibb Company Details
  • Table Merck Company Details
  • Table Vertex Pharmaceuticals Company Details
  • Table Baxter Company Details
  • Table BioMarin Company Details
  • Table Teva Pharmaceutical Industries Company Details
  • Table Global Rare Disease Treatment Market Size by Regions (Million US$) 2019-2025
  • Figure Global Rare Disease Treatment Market Size Share by Regions (2019-2025)
  • Figure Global Rare Disease Treatment Market Size Share by Regions in 2025
  • Figure United States Rare Disease Treatment Market Size Forecast (2019-2025)(Million USD)
  • Figure Europe Rare Disease Treatment Market Size Forecast (2019-2025)(Million USD)
  • Figure China Rare Disease Treatment Market Size Forecast (2019-2025)(Million USD)
  • Figure Japan Rare Disease Treatment Market Size Forecast (2019-2025)(Million USD)
  • Figure Southeast Asia Rare Disease Treatment Market Size Forecast (2019-2025)(Million USD)
  • Figure India Rare Disease Treatment Market Size Forecast (2019-2025)(Million USD)
  • Figure Central & South America Rare Disease Treatment Market Size Forecast (2019-2025)(Million USD)
  • Table Global Rare Disease Treatment Market Size by Product (2019-2025) (Million US$)
  • Figure Global Rare Disease Treatment Market Size by Product (2019-2025)
  • Figure Global Rare Disease Treatment Market Size by Product in 2025
  • Table Global Rare Disease Treatment Market Size by Application (2019-2025) (Million US$)
  • Figure Global Rare Disease Treatment Market Size by Application (2019-2025)
  • Figure Global Rare Disease Treatment Market Size by Application in 2025
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
Back to Top